Microbot Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Microbot Medical (MBOT).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

1S.Buy

4Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$6Upside to Avg. PT+395.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 23, 2026	Citizens	Daniel Stauder	Initiate	Market Outperform	$3
Oct 21, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Aug 14, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$5→$4
Jun 3, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$4
Apr 14, 2026	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Feb 10, 2026	B. Riley Securities	Anderson Schock	Initiate	Buy	$5
Dec 3, 2025	Roth Capital	Kyle Bauser	Initiate	Buy	$6
Nov 28, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Oct 15, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$12
Sep 11, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$9→$12
Apr 10, 2025	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$9
Jan 24, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Raise	Buy	$7→$9
Jun 3, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$7
Apr 16, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$8→$7

Analyst Ratings News

PRO
Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5

Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.

Benzinga Newsdesk

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

Avi Kapoor

Microbot Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

People Also Watch

People Also Watch

Microbot Medical Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Microbot Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5

PROHC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

PROB. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PROLUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PROHC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday

People Also Watch

People Also Watch

PRO
Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target

PRO
B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4

PRO
HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target